Report Content
Chapter 1 Methodology & Scope
1.1 Market scope & definitions
1.2 Research design
1.2.1 Research approach
1.2.2 Data collection methods
1.3 Base estimates & calculations
1.3.1 Base year calculation
1.3.2 Key trends for market estimation
1.4 Forecast model
1.5 Primary research and validation
1.5.1 Primary sources
1.5.2 Data mining sources
Chapter 2 Executive Summary
2.1 Industry 3600 synopsis
Chapter 3 Industry Insights
3.1 Industry ecosystem analysis
3.2 Industry impact forces
3.2.1 Growth drivers
3.2.1.1 Growing geriatric population
3.2.1.2 Rise in the prevalence of chronic diseases and lifestyle-related disorders
3.2.1.3 Rising adoption of telehealth services and remote communications
3.2.2 Industry pitfalls & challenges
3.2.2.1 High cost of molecular diagnostics tools
3.2.2.2 Lack of skilled professionals
3.3 Growth potential analysis
3.4 Regulatory landscape
3.5 Technological landscape
3.5.1 Core technologies
3.5.2 Adjacent technologies
3.6 Pricing analysis, 2023
3.6.1 By region
3.6.2 By key player
3.7 Future market trends
3.8 Porter’s analysis
3.9 PESTEL analysis
Chapter 4 Competitive Landscape, 2023
4.1 Introduction
4.2 Company market share analysis
4.3 Company matrix analysis
4.4 Competitive analysis of major market players
4.5 Competitive positioning matrix
4.6 Strategy dashboard
Chapter 5 Market Estimates and Forecast, By Product, 2021 – 2032 ($ Mn)
5.1 Key trends
5.2 Glucose diagnostic kits
5.3 Cardiometabolic diagnostic kits
5.4 Infectious disease testing kits
5.5 Hematology testing kits
5.6 Coagulation diagnostic kits
5.7 Cancer marker testing kits
5.8 Other products
Chapter 6 Market Estimates and Forecast, By Test Type, 2021 – 2032 ($ Mn)
6.1 Key trends
6.2 Flow cytometry
6.3 Hematology test
6.4 Microbiology and infectious test
6.5 Coagulation test
6.6 Immunoprotein
6.7 Routine and special chemistry
6.8 Other test types
Chapter 7 Market Estimates and Forecast, By End-Use, 2021 – 2032 ($ Mn)
7.1 Key trends
7.2 Operation room
7.3 Intensive care unit
7.4 Emergency rooms
7.5 Other end-users
Chapter 8 Market Estimates and Forecast, By Region, 2021 – 2032 ($ Mn)
8.1 Key trends
8.2 North America
8.2.1 U.S.
8.2.2 Canada
8.3 Europe
8.3.1 Germany
8.3.2 UK
8.3.3 France
8.3.4 Spain
8.3.5 Italy
8.3.6 Netherlands
8.3.7 Rest of Europe
8.4 Asia Pacific
8.4.1 China
8.4.2 Japan
8.4.3 India
8.4.4 Australia
8.4.5 South Korea
8.4.6 Rest of Asia Pacific
8.5 Latin America
8.5.1 Brazil
8.5.2 Mexico
8.5.3 Argentina
8.5.4 Rest of Latin America
8.6 Middle East and Africa
8.6.1 Saudi Arabia
8.6.2 South Africa
8.6.3 UAE
8.6.4 Rest of Middle East and Africa
Chapter 9 Company Profiles
9.1 Abbott Laboratories
9.2 Becton, Dickinson and Company
9.3 Bio-Rad Laboratories, Inc.
9.4 Danaher Corporation
9.5 F. Hoffmann-La Roche Ltd.
9.6 GE HealthCare Technologies, Inc.
9.7 Hologic, Inc.
9.8 Johnson & Johnson
9.9 Koninklijke Philips N.V.
9.10 Medtronic plc
9.11 Nihon Kohden Corporation
9.12 Nova Biomedical
9.13 Siemens Healthineers AG
9.14 Sysmex Corporation
9.15 Thermo Fisher Scientific Inc.
